Prosensa receives £7.5m milestone payment as part of its program with GlaxoSmithKline in Duchenne Muscular Dystrophy
15-Oct-2010
- Netherlands
Under their collaboration, Prosensa and GSK have several further late-stage clinical trials underway.
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.